Ozagrel Na intravenous drip 80mg “Takata” is a Takada Pharmaceutical product containing sodium ozagrel, which inhibits thromboxane A2 synthase to reduce platelet aggregation. It is used in the treatment of ischemic stroke and other thrombotic disorders. The product is 80mg 4mL 1 bottle, YJ code 3999411H1031.
Ozagrel Na intravenous drip 80mg “Takata”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →